[Pseudohyperaldosteronism].
D000293:Adolescent; D000328:Adult; D004485:Eczema / Q000188:drug therapy; D005477:Fluprednisolone / Q000009:adverse effects* / Q000031:analogs & derivatives; D006034:Glycyrrhetinic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D006035:Glycyrrhiza; D019695:Glycyrrhizic Acid; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010946:Plants, Medicinal; D019966:Substance-Related Disorders / Q000150:complications
C010958:9-fluoroprednisolone; D019695:Glycyrrhizic Acid; D005477:Fluprednisolone; D006034:Glycyrrhetinic Acid
Pseudohiperaldosteronismo.